Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Ranking of 20 Drug Companies' Sales Forces Shows Productivity Flat or Declining
- A ranking of drug company sales productivity shows Gilead gets the most revenues in return for every dollar invested in reps and marketing. At the other end of the table, Sepracor gets the least bang for its sales, general and administrative buck see table below. ...
- Blog posts 2009-02-24
- Ranking of 20 Drug Companies Shows Sales Force Effectiveness Reaching Plateau
- A ranking of 20 drug companies by sales and marketing productivity shows that 10 companies saw upward trends in effectiveness in Q2 2009. Last quarter, 13 companies had upward trends. The numbers indicate that companies have started to reach a plateau in their efforts to wring more revenues out of...
- Blog posts 2009-08-07
- GSK and Others See Massachusetts Showdown Over Drug-Marketing Reform
- There are two ideas floating in the world of politics to curb the way drug companies give doctors gifts and often biased information. One of them is a good idea, and one of them is a bad idea. Drug companies -- such as GlaxoSmithKline -- have chosen...
- Blog posts 2008-08-08
- Ranking of 20 Drug Companies by Sales Force Effectiveness Shows Improvement in Q1
- A ranking of 20 drug companies on sales and marketing productivity shows upward trends in effectiveness in Q1 2009. At the top of the table is AIDS drug specialist Gilead. At the bottom of the table is vanity pharma play Medicis. by Jim Edwards
- Blog posts 2009-05-14
- Pharma Roundup: Schering-Plough Surveys Investors, Wyeth Defended, and More
- Schering-Plough shareholders to have say on executive compensation, U.S. drug sales predictions lowered, McCain and Obama both promise hard line on Big Pharma. Also: two lawyers condemn unfounded anti-Wyeth opinions. by John Maas
- Blog posts 2008-10-29
Additional Resources
- Dendrite International acquires a European Company
- MORRISTOWN, N.J.--BUSINESS WIRE--May 8, 1996--Dendrite International, Inc. (NASDAQ/NMS:DRTE), the world's largest supplier of enterprise-wide customer management solutions to the pharmaceutical industry, today announced that it has signed an agreement to acquire SRCI S.A. (Montigny-le-Bretonneux, France), the largest provider of custom-designed sales force management systems in France for the Over-The Counter...
- Research articles 1996-05-08
- Elan Management Creates Self-Enrichment Plan as Pfizer-Wyeth Deal Threatens Bapineuzumab
- UPDATE: Elan says the share awards are part of "the normal annual compensation process" at Elan. See Elan's full statement in the comments section below. Elan's senior management have hatched a plan to enrich themselves in the event of a sale or takeover of their troubled...
- Blog posts 2009-02-17
- Amylin v. Eastbourne Slideshow Battle; It's All About the Stock Price
- Amylin and Eastbourne Capital, locked in a fight for control of Amylin's board of directors, have escalated their war in the only way that beancounters know how: duelling presentations. You can see Amylin's here and a summary of Eastbourne's here. Eastbourne has kept it...
- Blog posts 2009-05-06
- Pharma Roundup: Pfizer Examined; Merck, UPS, and Wholesalers; and More
- Pfizer's dangerous tendency to save management instead of its operations -- ... is one of the company's problems, according to some commentary in this analysis of the Biggest Pharma. Yes, it is the largest, but that certainly doesn't immunize Pfizer against the tremendous pressures of the current climate -- especially...
- Blog posts 2009-01-20
- GlaxoSmithKline Employees Fume Over Latest Round of Layoffs
- GlaxoSmithKline is historically terrible at handling layoffs news, and the round of job cuts that appears imminent is no exception. (Update: the official announcement is coming on Wednesday.) As usual, the news is being debated all over the net before management has gotten out of bed just like last time....
- Blog posts 2008-11-04
- Amgen More Dependent on Denosumab Than Ever, But What If FDA Delays Approval?
- Amgen's Q4 results showed, again, how dependent the company is on the FDA coming up with a solid approval for denosumab, its osteoporosis drug. Revenues were down a little bit to $3.6 billion, but expenses ballooned. The revenue yield on its sales dollars collapsed 23 percent from...
- Blog posts 2009-01-27
- Alcon Incorporated Q3 2007 Earnings Call Transcript
- Question-and-Answer Session Operator Thank you. [Operator Instruction] please stand by for your first question. Your first question will be from the line of Peter Bye of Jefferies & Co. Peter Bye – Jefferies & Co Thanks and good morning. I apologize if you’ve already...
- Earnings calls 2007-10-25
- Need to know: Time Warner falls 7%... Greggs sales up... Kier deal
- View video and Need to Know interactive heatmap Economics Interest rates: The Bank of England should cut interest rates by either a half-point or a full percentage point today, The Times Monetary Policy Committee recommended in a split vote. Three of the nine members of the panel said that no...
- News items 2009-08-07
- Forest Laboratories: Finding Ways to Bring Drugs to Market — Fast
- Pfizer may be big, but Forest Laboratories is nimble. The smaller company competes by ushering drugs through FDA red tape in record time. Giant: Pfizer Shadow Success: Forest Laboratories, Inc. Pfizer market cap: $96.56 billion;...
- Articles 2009-06-10
- The Pfizer-Shire Deal Worst-Case Scenario
- Earlier this week shares of Shire rose on rumors that Pfizer may be interested in acquiring the company, which is best-known for its ADHD drug Adderall XR. The notion that Pfizer is in acquisition mode has been driving people crazy for days. (See BNET's coverage of Pfizer Pfever here.) ...
- Blog posts 2009-01-07
- Tongjitang Chinese Medicines Co. Q3 2009 Earnings Call Transcript
- Question-and-Answer Session Operator Operator instructions. We'll go first to Katherine Lu of Oppenheimer. Unidentified Analyst Good morning, this is inaudible calling for Katherine Lu from Oppenheimer. Congratulation on inclusion of Xianling Gubao into the essential drug list. Looks like this is the only drug that is included in...
- Earnings calls 2009-11-18
- Five Masters of the Boardroom
- Challenging times call for extraordinary board members who can thwart corporate chaos. Here are five who shine. img.boardmember {border:4px solid #edece7; background:#fff; padding:4px; float:right; margin:0px 0 10px 10px; } ...
- Articles 2008-10-15
- CEGEDIM Announces Acquisition Of Target Software
- CEGEDIM, a European provider of CRM solutions for the healthcare industry, has announced it has acquired Target Software, Inc., a pharmaceutical CRM provider in the U.S. Target Software licenses its suite of CRM, sales force automation and drug sample management applications, known as Target SFA, to many U.S. pharmaceutical companies....
- Research articles 2005-05-01
- AZ looks to auto plants for efficiency gurus
- Years ago, Japanese car manufacturers turned to management gurus to make their plants more efficient. Now, AstraZeneca is hiring automotive gurus to apply their efficiencies to drug production, the Financial Times reports. It's yet another example of how pharma is borrowing from other industries in an effort to cut costs...
- News items 2009-10-26
- << Previous
- page 1 of 1
- Next >>
